限制性红细胞输血策略的依据及输血阈值

doi:10.3969/j.issn.1671-2587.2016.01.027

临床输血与检验 ›› 2016, Vol. 18 ›› Issue (1): 90-94.DOI: 10.3969/j.issn.1671-2587.2016.01.027

• 综述 • 上一篇

限制性红细胞输血策略的依据及输血阈值

岑宪铭

543002 广西梧州市中心血站。

收稿日期:2015-08-03 出版日期:2016-02-20 发布日期:2016-10-10
作者简介:岑宪铭（1961-）,男,广西梧州人,主任医师,学士,主要从事输血技术工作,(Tel)0774-3816890(E-mail)1780672097@qq.com。

Received:2015-08-03 Online:2016-02-20 Published:2016-10-10

摘要/Abstract

中图分类号:

R457.1

岑宪铭. 限制性红细胞输血策略的依据及输血阈值[J]. 临床输血与检验, 2016, 18(1): 90-94.

[1] WHO.Blood safety and clinical technology strategy 2000-2003[J]. Geneva, 2001,2-3.
[2] Linden PV.Anemia in critically ill patients:How much can they tolerate? [J]Transfusion Alternative in Transfusion Medicine,2008,4(4):121-128.
[3] Hébert PC,WellS G,Blajchman MA,et al.A multicenter,ranodomized,controlled clinical trial of transfusion requirements in critical care[J].N Engl J Med,1999,340(6):409-417.
[4] Lacroix J,Hébert PC,Hutchison JS,et al.Transfusion strategies for patients in pediatric intensive care units[J].The N Engl J Med,2007.356(16):1609-1619.
[5] Grover M,Talwalkar MS,Casbard A,et al.Silent myocardial ischaemia and haemoglobin concentration:a randomized controlled trial of transfusion strategy in lower limb arthroplasty[J].Vox Sanguinis,2006,90(2):105-112.
[6] Hajjar LA,Vincent JL,Galas FR,et al.Transfusion requirements after cardiac surgery:the TRACS randomized controlled trial[J].JMMA,2010,304(14):1559-1567.
[7] Carson JL,Terrin ML, Noveck H,et al.Liberal or restrictive transfusion in high-risk patients after hip surgery[J]. N Engl J Med,2011,365(26):2453-2462.
[8] Vuille-Lessard É,Boudreault D,Girard F,et al.Postoperative anemia dose not impede functional outcome and quality of life early after hip and knee arthroplasties[J].Transfusion,2012,52(2):261-270.
[9] Shehata N,Burns LA,Nathan H,et al.A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery[J].Transfusion,2012,52(1):91-99.
[10] Cooper HA,Rao SV,Greenberg MD,et al.Conservative versus liberal red cell transfusion in acute myocardial infarction(the CRIT randomized Pilot Study) [J].Am J Cardiol,2011,108(8):1108-1111.
[11] Villanueva C,Colomo A,Bosch A,et al.Transfusion strategies for acute upper gastrointestinal bleeding[J].N Engl J Med,2013,368(1):11-21.
[12] Robitaille N,Lacroix J,Alexandrov L,et al.Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation:a Canadian blood and marrow transplant group trial[J].Biol Blood Marrow Transplant,2013,19(3):468-473.
[13] Messmer K.Tissue oxygenation/tolerance of anemia[J].Transfusion Alternative in Transfusion Medicine,2003,4(s6):4-5.
[14] Nuttall GA,Brost BC,Connis RT,et al.Practice guidelines for perioperative blood transfusion and adjuvant therapies:an updated report by the American Society of Anesthesiologists Task Force on perioperative blood transfusion and adjuvant therapies[J]. Anesthesiology,2006,105(1):198-208.
[15] 邓硕曾,叶菱,刘进.怎样突破我国科学用血合理用血的瓶颈[J].中国输血杂志,2008,21（7）：489-490.
[16] Carson JL,Carless P. The evidence base for red blood cell transfusion[J].ISBT Science Series,2013,8(1):89-92.
[17] Corwin HL.Critical care issues for the nephrologist:anemia and red blood cell transfusion in the critically ill[J].Semin in Dial,2006,19(6):513-516.
[18] Retter A,Wyncoll D, Pearse R,et al.Guidelines on the management of anaemia and red cell transfusion in adult ill patients[J].Br J Haematol,2013,160(4):445-464.
[19] Goodnough LT,Schrier SL.Evaluation and management of anemia in the elderly[J].American Journal of Hematology,2014,89(1):88-96.
[20] 卢瑾,田兆嵩.危重患者的输血[J].中国输血杂志,2007,20（2）：175-178.
[21] Engelfriet CP, Reesink HW, Mccullough J. Perioperative triggers for red cell transfusions[J].Vox Sanguinis,2002,82(4):215-216.
[22] Carson JL,Grossman BJ,Kleinman S,et al.Red blood cell transfusion:a clinical practice guideline from the AABB[J].Ann Intern Med,2012,157(1):49-58.
[23] Carson JL, Noveck H,Berlin JA,et al.Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion[J].Transfusion,2002,42(7):812-818.
[24] Goodnough LT.Anemia,blood transfusion,and clinical outcomes in patients with cardiovascular risk factors[J].Transfusion Alternatives in Transfusion Medicine,2003,5(3):352-355.
[25] 金希希,孟忠华,徐伟娟.大失血处理指南[J].国际输血及血液学杂志,2007,30（6）：568-571.
[26] Habler O,Meier J,Pape A,et al.Telerance to perioperative anemia,mechanisms,influencing factors and limits[J].Der Anaesthesist,2006,55(11):1142-1156.
[27] Viele MK,Weiskopf RB.What can we learn about the need for transfusion from patients who refuse blood? the experience with Jehovah`s Witnesses[J].Transfusion,1994,34(5):396-401.
[28] Hébert PC,Mcdonald BJ,Tinmouth A.Overview of transfusion practices in perioperative and critical care[J].Transfusion Alternatives in Transfusion Medicine,2005,6(4):15-22.
[29] Massicotte L,Lénis S,Thibeault L,et al.Reply:effect of low central venous pressure and phlebotomy on blood product transfusion requirement during liver transplantation[J].Liver Transplant,2006,12(8):1303-1304.
[30] Carson JL,Poses RM,Spence RK,et al.Severity of anaemia and operative mortality and morbidity[J].Lancet,1988,1(8588):727-729.
[31] Carson JL,Duff A,Poses RM,et al.Effect of anaemia and cardiovascular disease on surgical mortality and morbidity[J].Lancet,1996,348(9034):1055-1060.
[32] 孙天胜.骨科输血策略[J].中国输血杂志,2012,25（3）：193-194.
[33] Corwin HL.Anemia and blood transfusion in the critically ill patient[J].Transfusion Alternatives in Transfusion Medicine,2005,6(3):38-42.
[34] Mudumbai SC,Cronkite R,Hu KU,et al.Association of admission hematocrit with 6-month and 1-year mortality in intensive care unit patients[J].Transfusion,2011,51(10):2148-2159.
[35] Wu WC,Rathore SS,Wang YF,et al.Blood transfusion in elderly patients with acute myocardial infarction[J].N Engl J Med,2001,345(17):1230-1236.
[36] 何子毅,田兆嵩.用药物替代输血治疗[J].中国输血杂志,2006,19（6）：503-507.
[37] 中华人民共和国卫生部.临床输血技术规范[S].2000,6,1.

限制性红细胞输血策略的依据及输血阈值

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	贾彦军, 赵续影, 魏珍珍. 白藜芦醇对小鼠血小板氧化应激和衰老指标及储存时间的影响^*[J]. 临床输血与检验, 2021, 23(2): 137-141.
[2]	王磊, 吴学忠. 受血者与供血者Rh（D、C、c、E、e）抗原相容情况的回顾性分析[J]. 临床输血与检验, 2021, 23(2): 181-185.
[3]	甘珊, 段灵, 胡红兵. 新生儿高胆红素血症换血治疗用血情况分析^*[J]. 临床输血与检验, 2021, 23(2): 185-188.
[4]	段秉政, 王淑莲, 连俊慧, 陶琳, 高玉云. 直接抗人球蛋白试验在患者输血疗效中的临床意义分析[J]. 临床输血与检验, 2021, 23(2): 189-191.
[5]	杨春晨, 戎瑞明, 李杨, 蒋密, 周蓉. 基于Cov-AHP-模糊综合评价法构建输血病历质量评价模型[J]. 临床输血与检验, 2021, 23(2): 192-196.
[6]	郭伟洁, 刘泽雅, 张凡, 赫喜荣, 常玥, 陈利达, 王文静, 芦宏凯. 中国献血人群意外抗体阳性率的Meta分析[J]. 临床输血与检验, 2021, 23(2): 202-212.
[7]	张保萍, 张嵘, 王文婷, 安群星, 尹文, 胡兴斌. 谱细胞鉴定剂量效应分析偏差致抗-C抗体漏检1例[J]. 临床输血与检验, 2021, 23(2): 236-239.
[8]	权军辉, 张明刚, 姜侠, 韩梅宁. 携RHD-CE（2-9）-D基因并产生抗-D、抗-E抗体1例[J]. 临床输血与检验, 2021, 23(2): 239-241.
[9]	骆群, 王雨婧, 卓海龙. 2020年免疫血液学研究进展^*[J]. 临床输血与检验, 2021, 23(2): 248-255.
[10]	汪晓晓, 郭建荣. 自体输血在老年患者手术中的应用价值及风险分析^*[J]. 临床输血与检验, 2021, 23(2): 259-262.
[11]	黄佳丽, 刘正婷, 陈尚良, 周义文. 亚甲蓝光病毒灭活血浆的研究进展^*[J]. 临床输血与检验, 2021, 23(2): 268-272.
[12]	贺敏威, 孙苏静, 周欠欠, 王小慧, 詹林盛. 2020年度输血医学科研新进展[J]. 临床输血与检验, 2021, 23(1): 13-17.
[13]	郝一文. 以一种整体、动态观评估及评价红细胞输注的指征及效果[J]. 临床输血与检验, 2020, 22(6): 590-593.
[14]	黄蓉, 陈婷婷, 朱龙飞, 凌玉, 史融冰, 胡文静. 母源性新生儿疾病输血状况分析^*[J]. 临床输血与检验, 2020, 22(6): 610-612.
[15]	张黎, 李雪莲, 胡章雪. 86例新生儿输注红细胞临床多因素分析[J]. 临床输血与检验, 2020, 22(6): 613-616.